SCHEMBL7185747

SCHEMBL7185747

COc1cccc(OC)c1/C=C/C(=O)c1ccc(O)cc1

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.88
MAOB P27338 1/20 0.71
CTSL P07711 4/20 0.63
CAPN1 P07384 3/20 0.63
CTSB P07858 3/20 0.63
TDP1 Q9NUW8 1/20 0.62
MAOA P21397 1/20 0.59
MAPT P10636 2/20 0.57
P4HB P07237 1/20 0.57
CALM1 P0DP23 1/20 0.57
RAB9A P51151 1/20 0.57
MEN1 O00255 1/20 0.57
ALDH1A1 P00352 1/20 0.57
F3 P13726 1/20 0.57
XDH P47989 1/20 0.57
KMT2A Q03164 1/20 0.57
CYP1A1 P04798 1/20 0.57
CYP1A2 P05177 1/20 0.57
CYP2D6 P10635 1/20 0.57
DPP4 P27487 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7185751 1.00 ABCG2 (0.88) ABCG2MAOBCTSLCAPN1CTSB
SCHEMBL979719 0.87 ABCG2 (0.87) ABCG2MAOBMAOAMAPTRAB9A
SCHEMBL979720 0.87 ABCG2 (0.87) ABCG2MAOBMAOAMAPTRAB9A
SCHEMBL7192430 0.86 ABCG2 (0.85) ABCG2MAOBCTSLCTSBMAOA
SCHEMBL7101379 0.86 ABCG2 (0.85) ABCG2MAOBCTSLCTSBMAOA
SCHEMBL7185827 0.85 ABCG2 (0.63) ABCG2MAOBCTSLCAPN1CTSB
SCHEMBL7185831 0.85 ABCG2 (0.63) ABCG2MAOBCTSLCAPN1CTSB
SCHEMBL7184176 0.84 ABCG2 (0.61) ABCG2MAOBCTSLCAPN1CTSB
SCHEMBL7186899 0.84 ABCG2 (0.61) ABCG2MAOBCTSLCAPN1CTSB
SCHEMBL7184186 0.84 ABCG2 (0.61) ABCG2MAOBCTSLCAPN1CTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed